CNBC Top Stories

The CEO of Dubai Airports is very bullish about the future and expects passenger traffic to top 100 million by 2027.

Pharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including cancer treatments.

The firm aims "to strengthen its competitiveness amid an uncertain global business environment," Samsung Electronics said.

Wall Street's reaction to Palo Alto Networks' report seems overdone. Like its past two earnings sell-offs, we think investors should buy the dip.

China's sweeping moves on Friday to increase support for real estate will take time to show results, analysts said.

Scarlett Johansson's comments come after OpenAI paused the new ChatGPT AI voice "Sky."

Closing arguments in the New York criminal hush money trial of Donald Trump will take place after Memorial Day.

The ambiguity of Dimon's plans has made succession timing at JPMorgan one of the persistent questions for the bank's investors and analysts.

Cramer stressed how the Dow's record was propelled by stocks in a variety of sectors beyond technology, including industrials, pharmaceuticals and banks.

A recent report detailing a toxic culture at the FDIC described Chair Martin Gruenberg as having a "temper" and a "short fuse."

Peloton is in the middle of a broad restructuring as it looks to align the size of its business with its slowing sales and avoid a cash crunch.

JPMorgan Chase has seen its shares surge 40% over the past year, reaching a 52-week high on Monday before Dimon's comments dinged the stock.

Melius Research believes Apple's AI-enhanced iPhones could boost multiple parts of the technology giant's business.

In attempts to fix the country's $1.6 trillion student loan system, the Biden administration has routinely announced forgiveness of large shares of that debt.

Starting Monday, Wendy's will offer a $3 breakfast combination meal deal, following a similar yet limited value meal option by McDonald's.

Baby boomers make up a sizeable chunk of the retailers' shoppers and investors aren't convinced that Gen Z and Millennials will age into shopping at the stores.

Microsoft wants to deliver Windows PCs that can keep up with Apple's MacBooks on artificial intelligence performance and strong battery life.

The GLP-1 market has faced supply constraints in recent months as drugs like Ozempic and Wegovy continue to skyrocket in popularity.